Adaptive and maladaptive hypertrophic pathways: Points of convergence and divergence

Giulio Selvetella, Emilio Hirsch, Antonella Notte, Guido Tarone, Giuseppe Lembo

Research output: Contribution to journalArticle

Abstract

Myocardial hypertrophy is a response of cardiac muscle to altered conditions of haemodynamic overload caused by a large number of physiological and pathological conditions. Traditionally, it has been considered a beneficial mechanism. However, sustained hypertrophy has been associated with a significant increase in the risk of cardiovascular disease and mortality. Actually, many researchers are trying to understand whether left ventricular hypertrophy is a 'good' mechanism to stimulate or a 'bad' process to prevent. In this review we investigate the most common biochemical signaling pathways involved in the hypertrophic response to identify the precise role, either 'adaptive' or 'maladaptive', of each molecular pathway. Delinealing intracellular signaling pathways involved in the different aspects of cardiac hypertrophy will permit future improvements in the signaling that controls beneficial growth.

Original languageEnglish
Pages (from-to)373-380
Number of pages8
JournalCardiovascular Research
Volume63
Issue number3
DOIs
Publication statusPublished - Aug 15 2004

Fingerprint

Hypertrophy
Cardiomegaly
Left Ventricular Hypertrophy
Myocardium
Cardiovascular Diseases
Hemodynamics
Research Personnel
Mortality
Growth

Keywords

  • Left ventricular hypertrophy
  • Pressure overload
  • Signaling
  • Transgenic mice

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Adaptive and maladaptive hypertrophic pathways : Points of convergence and divergence. / Selvetella, Giulio; Hirsch, Emilio; Notte, Antonella; Tarone, Guido; Lembo, Giuseppe.

In: Cardiovascular Research, Vol. 63, No. 3, 15.08.2004, p. 373-380.

Research output: Contribution to journalArticle

Selvetella, Giulio ; Hirsch, Emilio ; Notte, Antonella ; Tarone, Guido ; Lembo, Giuseppe. / Adaptive and maladaptive hypertrophic pathways : Points of convergence and divergence. In: Cardiovascular Research. 2004 ; Vol. 63, No. 3. pp. 373-380.
@article{6ae0ecc40d6b4c978c1adef0ec5cb91e,
title = "Adaptive and maladaptive hypertrophic pathways: Points of convergence and divergence",
abstract = "Myocardial hypertrophy is a response of cardiac muscle to altered conditions of haemodynamic overload caused by a large number of physiological and pathological conditions. Traditionally, it has been considered a beneficial mechanism. However, sustained hypertrophy has been associated with a significant increase in the risk of cardiovascular disease and mortality. Actually, many researchers are trying to understand whether left ventricular hypertrophy is a 'good' mechanism to stimulate or a 'bad' process to prevent. In this review we investigate the most common biochemical signaling pathways involved in the hypertrophic response to identify the precise role, either 'adaptive' or 'maladaptive', of each molecular pathway. Delinealing intracellular signaling pathways involved in the different aspects of cardiac hypertrophy will permit future improvements in the signaling that controls beneficial growth.",
keywords = "Left ventricular hypertrophy, Pressure overload, Signaling, Transgenic mice",
author = "Giulio Selvetella and Emilio Hirsch and Antonella Notte and Guido Tarone and Giuseppe Lembo",
year = "2004",
month = "8",
day = "15",
doi = "10.1016/j.cardiores.2004.04.031",
language = "English",
volume = "63",
pages = "373--380",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Adaptive and maladaptive hypertrophic pathways

T2 - Points of convergence and divergence

AU - Selvetella, Giulio

AU - Hirsch, Emilio

AU - Notte, Antonella

AU - Tarone, Guido

AU - Lembo, Giuseppe

PY - 2004/8/15

Y1 - 2004/8/15

N2 - Myocardial hypertrophy is a response of cardiac muscle to altered conditions of haemodynamic overload caused by a large number of physiological and pathological conditions. Traditionally, it has been considered a beneficial mechanism. However, sustained hypertrophy has been associated with a significant increase in the risk of cardiovascular disease and mortality. Actually, many researchers are trying to understand whether left ventricular hypertrophy is a 'good' mechanism to stimulate or a 'bad' process to prevent. In this review we investigate the most common biochemical signaling pathways involved in the hypertrophic response to identify the precise role, either 'adaptive' or 'maladaptive', of each molecular pathway. Delinealing intracellular signaling pathways involved in the different aspects of cardiac hypertrophy will permit future improvements in the signaling that controls beneficial growth.

AB - Myocardial hypertrophy is a response of cardiac muscle to altered conditions of haemodynamic overload caused by a large number of physiological and pathological conditions. Traditionally, it has been considered a beneficial mechanism. However, sustained hypertrophy has been associated with a significant increase in the risk of cardiovascular disease and mortality. Actually, many researchers are trying to understand whether left ventricular hypertrophy is a 'good' mechanism to stimulate or a 'bad' process to prevent. In this review we investigate the most common biochemical signaling pathways involved in the hypertrophic response to identify the precise role, either 'adaptive' or 'maladaptive', of each molecular pathway. Delinealing intracellular signaling pathways involved in the different aspects of cardiac hypertrophy will permit future improvements in the signaling that controls beneficial growth.

KW - Left ventricular hypertrophy

KW - Pressure overload

KW - Signaling

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=3242774502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242774502&partnerID=8YFLogxK

U2 - 10.1016/j.cardiores.2004.04.031

DO - 10.1016/j.cardiores.2004.04.031

M3 - Article

C2 - 15276462

AN - SCOPUS:3242774502

VL - 63

SP - 373

EP - 380

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 3

ER -